Objectives: This study aimed to identify, measure and evaluate expected costs of innovative palonosetron-based antiemetic therapy versus ondansetron-based treatment, the ultimate aim being to ...

This makes the use of CEA inappropriate. [21] For this reason, a cost analysis of palonosetron versus ondansetron was conducted. Furthermore, the clinical superiority of palonosetron in preventing ...